Insights
Market commentary and guides
XJO & Market Direction
To discuss the implementation of our index trades either in CFDs, futures or other ASX instruments, please call the office on 1300 614 002.…
Lendlease: Is it a value trap?
We begin a closer look at Lendlease as an out-of-cycle recovery play and ask the question, value trap or plain value? FY22 Financial &…
We are buying this ETF…
1/12 update: IAA has rallied as expected. iShares Asia 50 The fund aims to provide investors with the performance of the S&P Asia 50TM…
Fisher & Paykel Healthcare: Earnings
Fisher & Paykel Healthcare Corporation expects group revenue to be higher in 2H than 1H due to historical hospital sales seasonality and destocking momentum.…
XJO & Market Direction
To discuss the implementation of our index trades either in CFDs, futures or other ASX instruments, please call the office on 1300 614 002.…
US Equities: Valuation Analysis
The market is at a valuation level where we’ll need to see evidence of earnings stabilizing, and forecasts being upgraded. The December numbers will…
We are buying this ETF…
iShares Asia 50 The fund aims to provide investors with the performance of the S&P Asia 50TM Index, beforefees and expenses. The index is…
Emerging Markets
Vanguard FTSE Emerging Markets Shares offers long-term value.
Brambles – Algo Buy
24/11 update: Brambles continues to find buying support. 14/11: BXB will likely form a higher low above the recent $10.88 pivot low. Watch the…
Xero
Xero is looking oversold and the chart pattern to watch is highlighted below.